latest news releases from the newsroom
Murray, Frank & Sailer LLP
Murray, Frank & Sailer Llp Announces Class Action Lawsuit On Behalf Of Purchasers Of Corporate Backed Trust Certificates Verizon New York Debenture-Backed Series 2004-1 -- JZG
NEW YORK, June 25, 2004 (PRIMEZONE) -- Murray, Frank & Sailer LLP announces that a class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of all persons who purchased Corporate Backed Trust Certificates Verizon New York Debenture-Backed Series 2004-1 (NYSE:JZG) (CUSIP:21988K800) (the "Certificates") from their first offering on or about January 5, 2004 through and including May 11, 2004 pursuant to a prospectus dated November 8, 2002, as supplemented by prospectus supplements dated January 5, 2004 and January 20, 2004 (collectively, the "Prospectus").
Injecto-Matic System Intl. Inc.
Injecto-Matic Systems International, Inc. Hires Harris Green Corp for Immediate Launch of Mosquito Pro Shield
CLEARWATER, Fla., June 25, 2004 (PRIMEZONE) -- Injecto-Matic Systems International, Inc. (OTC:IJMS), a publicly traded company headquartered in Toronto, Ontario, Canada, has hired Harris Green to enhance the marketing efforts of Mosquito Pro Shield. In conjunction with this, Injecto-Matic announces that the Mosquito Pro Shield is now for sale on the corporate Website of IJMS www.mosquitoproshield.com . This innovative product actually reverses the process of other insect-repelling products. It uses an all-natural repellant formula to create an insect-free zone surrounding the base unit up to 45 square feet.
Port of Houston Authority
PHA Commission Considers Bayport, Capital Improvement Matters
HOUSTON, June 25, 2004 (PRIMEZONE) -- The Port of Houston Authority (PHA) commission will consider several recommendations involving contract awards, bids and proposals, professional services and general administrative and operational matters during its public meeting beginning at 2 p.m. on Monday, June 28, 2004 in the 4th floor board room at 111 East Loop North (exit 29 off Loop 610). Chairman Jim Edmonds will preside over the meeting to be attended by Vice Chairman Kase Lawal, Commissioner Steve Phelps, Commissioner Jim Fonteno, Commissioner Jimmy Burke, Commissioner Cheryl Thompson-Draper, and Commissioner Janiece Longoria.
ViroPharma To Appeal Nasdaq Determination
EXTON, Pa., June 25, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by physician specialists and in hospital settings, including cytomegalovirus (CMV) and hepatitis C (HCV), announced today that it has received a notice from Nasdaq indicating that it did not comply with the minimum $50 million market value requirement for continued listing on the Nasdaq National Market, as set forth in Marketplace Rule 4450(b)(1)(A). ViroPharma intends to file a request for a hearing to appeal the Nasdaq staff's determination. The Company's stock will continue to be traded on the Nasdaq National Market pending a final decision by the Nasdaq Listing Qualifications Panel.
Coastal Holdings, Inc.
Coastal Holdings, Inc. in Negotiations to Acquire Interest in BioMedicom Inc.
HOUSTON , June 25, 2004 (PRIMEZONE) -- Coastal Holdings, Inc. (Pink Sheets:CSJJ) is pleased to announce that it is in negotiations to acquire a 35%-45% equity interest in BioMedicom Inc. (BIOMED). BIOMED will be an exhibitor at the International Congress of Radiology to be held June 27-29, 2004 at the Palais des Congres de Montreal. CSJJ CEO Andrea Cortellazzi will be in negotiations with BIOMED CEO Michael Berman prior to the start of the Congress in Montreal. CSJJ will announce the outcome of this meeting at a future date. The investment in BIOMED will be for a total of $2M with an initial deposit of $300,000 upon contract signing. As part of the investment, CSJJ would receive distribution rights in North America to SONOReal, a revolutionary add-on to any ultrasound system. This product makes 3D ultrasound imaging easy to learn, use and afford. It increases the productive life of an existing ultrasound system, enabling 3D visualization in real-time, while maintaining familiar protocols. SONOReal has received several regulatory clearances, notably from the ISO and the FDA.